Juan Carlos Pascual

Summary

Affiliation: Hospital de la Santa Creu i Sant Pau
Country: Spain

Publications

  1. ncbi Utilization of psychiatric emergency services by homeless persons in Spain
    Juan Carlos Pascual
    Universitat Autonoma de Barcelona, Barcelona, Spain
    Gen Hosp Psychiatry 30:14-9. 2008
  2. ncbi Immigrants and borderline personality disorder at a psychiatric emergency service
    J C Pascual
    Department of Psychiatry, Sta Creu i St Pau Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain
    Br J Psychiatry 193:471-6. 2008
  3. ncbi Neural correlates of impaired emotional discrimination in borderline personality disorder: an fMRI study
    Marc Guitart-Masip
    Cognitive Neuroscience Research Unit, Department of Psychiatry and Forensic Medicine, Universitat Autonoma de Barcelona, Hospital del Mar, Barcelona, Spain
    Prog Neuropsychopharmacol Biol Psychiatry 33:1537-45. 2009
  4. ncbi Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study
    Ana M Catafau
    Experimental Medicine, Clinical Pharmacology Discovery Medicine, Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline, 08005, Barcelona, Spain
    Psychopharmacology (Berl) 189:145-53. 2006
  5. ncbi Stages of change in dialectical behaviour therapy for borderline personality disorder
    Joaquim Soler
    Servei de Psiquiatria, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain
    Br J Clin Psychol 47:417-26. 2008
  6. ncbi Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder
    Joaquim Soler
    Department of Psychiatry, Sta. Creu and St. Pau Hospital, St. Antoni M Claret 167, 08025 Barcelona, Spain
    Am J Psychiatry 162:1221-4. 2005
  7. ncbi Discriminant validity of the ZKPQ in a sample meeting BPD diagnosis vs. normal-range controls
    Montserrat Gomà-i-Freixanet
    Department of Health Psychology, Universitat Autonoma de Barcelona, Catalonia, Spain
    J Pers Disord 22:178-90. 2008
  8. ncbi Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study
    Juan Carlos Pascual
    Department of Psychiatry, Sta Creu and St Pau Hospital, Barcelona, Spain
    J Clin Psychiatry 69:603-8. 2008
  9. ncbi [Somatic conditions in patients suffering from anxiety disorders]
    Juan Carlos Pascual
    Instituto de Atención Psiquiátrica, IAPS, Hospital del Mar, Departamento de Psiquiatria, Universidad Autonoma de Barcelona, Barcelona, Espana
    Med Clin (Barc) 130:281-5. 2008

Detail Information

Publications9

  1. ncbi Utilization of psychiatric emergency services by homeless persons in Spain
    Juan Carlos Pascual
    Universitat Autonoma de Barcelona, Barcelona, Spain
    Gen Hosp Psychiatry 30:14-9. 2008
    ....
  2. ncbi Immigrants and borderline personality disorder at a psychiatric emergency service
    J C Pascual
    Department of Psychiatry, Sta Creu i St Pau Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain
    Br J Psychiatry 193:471-6. 2008
    ..Several studies have suggested that immigrants have higher rates of psychiatric emergency service use and a higher risk of mental disorders such as schizophrenia than indigenous populations...
  3. ncbi Neural correlates of impaired emotional discrimination in borderline personality disorder: an fMRI study
    Marc Guitart-Masip
    Cognitive Neuroscience Research Unit, Department of Psychiatry and Forensic Medicine, Universitat Autonoma de Barcelona, Hospital del Mar, Barcelona, Spain
    Prog Neuropsychopharmacol Biol Psychiatry 33:1537-45. 2009
    ..Furthermore, activity at this site correlated with impulsivity score in the Zuckerman-Kuhlman Personality Questionnaire. Our findings may be related to cognitive impairment that may be characteristic of the disorder...
  4. ncbi Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study
    Ana M Catafau
    Experimental Medicine, Clinical Pharmacology Discovery Medicine, Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline, 08005, Barcelona, Spain
    Psychopharmacology (Berl) 189:145-53. 2006
    ..To assess the paroxetine-induced serotonin transporter (SERT) occupancy (SERTocc) using in vivo (123)I-ADAM SPECT...
  5. ncbi Stages of change in dialectical behaviour therapy for borderline personality disorder
    Joaquim Soler
    Servei de Psiquiatria, Hospital de la Santa Creu i Sant Pau, Universitat Autonoma de Barcelona, Barcelona, Spain
    Br J Clin Psychol 47:417-26. 2008
    ..The study aims at evaluating the suitability of applying the transtheoretical model (TTM) stage-of-change construct to the treatment with dialectical behaviour therapy (DBT) of borderline personality disorder (BPD)...
  6. ncbi Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder
    Joaquim Soler
    Department of Psychiatry, Sta. Creu and St. Pau Hospital, St. Antoni M Claret 167, 08025 Barcelona, Spain
    Am J Psychiatry 162:1221-4. 2005
    ..The mean dose of olanzapine was 8.83 mg/day. CONCLUSIONS: A combined psychotherapeutic plus pharmacological approach appears to lower dropout rates and constitutes an effective treatment for borderline personality disorder...
  7. ncbi Discriminant validity of the ZKPQ in a sample meeting BPD diagnosis vs. normal-range controls
    Montserrat Gomà-i-Freixanet
    Department of Health Psychology, Universitat Autonoma de Barcelona, Catalonia, Spain
    J Pers Disord 22:178-90. 2008
    ..Likewise, this model correctly classified 88% of subjects with a kappa index of 0.73. The AFFM of personality appears to have a substantial power for predicting SCID-II interview-based BPD diagnosis...
  8. ncbi Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study
    Juan Carlos Pascual
    Department of Psychiatry, Sta Creu and St Pau Hospital, Barcelona, Spain
    J Clin Psychiatry 69:603-8. 2008
    ..The aim of this double-blind, placebo-controlled study was to evaluate the efficacy and tolerability of ziprasidone in the treatment of adult patients with borderline personality disorder...
  9. ncbi [Somatic conditions in patients suffering from anxiety disorders]
    Juan Carlos Pascual
    Instituto de Atención Psiquiátrica, IAPS, Hospital del Mar, Departamento de Psiquiatria, Universidad Autonoma de Barcelona, Barcelona, Espana
    Med Clin (Barc) 130:281-5. 2008
    ....